Yttrium-90 Clinical Trials
3 recruitingDrug
Not Applicable1Phase 11Phase 21
Showing 1–3 of 3 trials
Recruiting
Phase 2
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
CholangiocarcinomaBile Duct CancerCholangiocarcinoma Non-resectable+2 more
Beth Israel Deaconess Medical Center30 enrolled1 locationNCT05655949
Recruiting
Not Applicable
A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Li Qiang286 enrolled1 locationNCT07070076
Recruiting
Phase 1
Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
Liver Malignancy
University of Michigan Rogel Cancer Center70 enrolled1 locationNCT04518748